Kyoko Nagao

Dr. Kyoko Nagao

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
HPHira Peracha
Hira Peracha
KSKazuki Sawamoto
Kazuki Sawamoto
LALauren Averill
Lauren Averill
HKHeidi Kecskemethy
Heidi Kecskemethy
MTMary Theroux
Mary Theroux
Shunji TomatsuShunji Tomatsu
Shunji Tomatsu

1 October 2016 in Journal of the American Academy of Audiology
Verified
Journal Article
Closed access
PDF file
KNKyoko Nagao
Kyoko Nagao
TRTammy Riegner
Tammy Riegner
JPJennifer Padilla
Jennifer Padilla
LGL. Ashleigh Greenwood
L. Ashleigh Greenwood
JLJessica Loson
Jessica Loson
TMThierry Morlet
Thierry Morlet
Background:Although auditory processing disorder (APD) is a widely recognized impairment, its prevalence and demographic characteristics are not precisely known in the pediatric population.Purpose:To examine the demographic characteristics of children diagnosed with APD at a tertiary health-care facility and the prevalence of pediatric APD.Research Design:A cross-sectional study.Study Sample:A total of 243 children (149 boys and 94 girls) who were referred to the Nemours Audiology Clinics in the Delaware Valley for an APD evaluation. The mean ages were 9.8 yr for boys and 9.7 yr for girls. Out of 243 children referred for an APD evaluation, 94 children exhibited one or more auditory processing deficits in the areas of auditory closure, auditory figure ground, binaural integration, binaural separation, and temporal processing.Data Collection and Analysis:Demographic and audiological data, clinical history (parental reports on prenatal and postnatal information, birth weight and height, medical and developmental history, otologic/audiological history, education information, behavioral characteristics), and results of the APD test battery were retrospectively obtained from the electronic medical records of each participant. The prevalence of APD was estimated using the total number of students enrolled in the same school attended by each participant in the 2011 academic year as cohort.Results:The prevalence of APD was 1.94 per 1,000 children in this study. We found that prevalence of APD among the children who attended private schools was more than two times higher than the children who attended public schools. The results also revealed that the majority of children referred to the clinics were Caucasian (85.6%), whereas minority groups were underrepresented for this geographical area with only 3.7% of Hispanic or Latino children and 5.8% of Black or African American children.Conclusions:The estimated prevalence of APD in the current study was lower than the previously published estimates. The difference might be due to the diagnosis criteria of APD among studies as well as the use of school enrollment number as the referenced population to estimate prevalence in our study. We also found a significant difference in APD prevalence depending on the school types. The findings of higher prevalence rates among the children attending private schools and higher proportion of Caucasians children referred for APD evaluation suggest that more children among those in public schools and in the Hispanic and African American groups should have been referred for an APD evaluation. Hence, the current estimate is likely an underestimate of the actual APD prevalence. The low percentage of Hispanic or African American children referred to the clinic for APD evaluations may be related to the socioeconomic status and linguistic differences among the concerned families. The results of this study raise the importance of adapting the APD test battery for children with a different linguistic background as well as increasing awareness of available clinical resources to all families in our area.

1 June 2016 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
EYEriko Yasuda
Eriko Yasuda
YSYasuyuki Suzuki
Yasuyuki Suzuki
TSTsutomu Shimada
Tsutomu Shimada
KSKazuki Sawamoto
Kazuki Sawamoto
WMWilliam G. Mackenzie
William G. Mackenzie
Shunji TomatsuShunji Tomatsu
Shunji Tomatsu

4 August 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
JWJeremy Wolfberg
Jeremy Wolfberg
KCKeerthana Chintalapati
Keerthana Chintalapati
Shunji TomatsuShunji Tomatsu
Shunji Tomatsu
KNKyoko Nagao
Kyoko Nagao
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a deficiency of one of the enzymes involved in the degradation of glycosaminoglycans. Hearing loss is a common clinical presentation in MPS. This paper reviews the literature on hearing loss for each of the seven recognized subtypes of MPS. Hearing loss was found to be common in MPS I, II, III, IVA, VI, and VII, and absent from MPS IVB and MPS IX. MPS VI presents primarily with conductive hearing loss, while the other subtypes (MPS I, MPS II, MPS III, MPS IVA, and MPS VII) can present with any type of hearing loss (conductive, sensorineural, or mixed hearing loss). The sensorineural component develops as the disease progresses, but there is no consensus on the etiology of the sensorineural component. Enzyme replacement therapy (ERT) is the most common therapy utilized for MPS, but the effects of ERT on hearing function have been inconclusive. This review highlights a need for more comprehensive and multidisciplinary research on hearing function that includes behavioral testing, objective testing, and temporal bone imaging. This information would allow for better understanding of the progression and etiology of hearing loss. Owing to the prevalence of hearing loss in MPS, early diagnosis of hearing loss and annual comprehensive audiological evaluations are recommended.

25 January 2019 in International Journal of Audiology
Verified
Journal Article
Closed access
TMThierry Morlet
Thierry Morlet
KNKyoko Nagao
Kyoko Nagao
LGL. Ashleigh Greenwood
L. Ashleigh Greenwood
RCR. Matthew Cardinale
R. Matthew Cardinale
RGRebecca G. Gaffney
Rebecca G. Gaffney
TRTammy Riegner
Tammy Riegner
Objective: The objectives were to investigate the function of central auditory pathways and of the medial efferent olivocochlear system (MOCS). Design: Event-related potentials (ERP) were recorded following the delivery of the stimulus /da/ in quiet and in ipsilateral, contralateral, and binaural noise conditions and correlated to the results of the auditory processing disorders (APD) diagnostic test battery. MOCS function was investigated by adding ipsilateral, contralateral, and binaural noise to transient evoked otoacoustic emission recordings. Auditory brainstem responses and pure tone audiogram were also evaluated. Study Sample: Nineteen children (7 to 12 years old) with APD were compared with 24 age-matched controls. Results: Otoacoustic emissions and ABR characteristics did not differ between groups, whereas ERP latencies were significantly longer and of higher amplitudes in APD children than in controls, in both quiet and noise conditions. The MOCS suppression was higher in APD children. Conclusions: Findings indicate that children with APD present with neural deficiencies in both challenging and nonchallenging environments with an increase in the timing of several central auditory processes correlated to their behavioural performances. Meanwhile, their modulation of the auditory periphery under noisy conditions differs from control children with higher suppression.

1 April 2018 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
KNKyoko Nagao
Kyoko Nagao
TMThierry Morlet
Thierry Morlet
EHElizabeth Haley
Elizabeth Haley
JPJennifer Padilla
Jennifer Padilla
JNJulianne Nemith
Julianne Nemith
Shunji TomatsuShunji Tomatsu
Shunji Tomatsu